Anthony J. Polverino
Director/Board Member at BRAINSTORM CELL THERAPEUTICS INC.
Net worth: 13 811 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Irit Arbel | M | 64 | 24 years | |
| Uri Yablonka | M | 47 | 10 years | |
| Stacy Lindborg | M | 53 | 4 years | |
| Yael Gothelf | M | - | 17 years | |
| Nir Naor | M | 50 | 1 years | |
| Christopher Astle | M | 45 |
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| Bob Dagher | M | 55 | 1 years | |
| Susan Mahony | M | 59 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Alla Patlis | F | 37 | 12 years | |
| Troy Cox | M | 60 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Menghisteab Bairu | M | 63 | 3 years | |
| Chaim Lebovits | M | 53 | 17 years | |
| Kelvin Neu | M | 50 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 4 years |
| Jacob Frenkel | M | 81 | 4 years | |
| Yossef Levy | M | - | - | |
| Mary Kay Turner | F | - | 7 years | |
| Bruce Hart | M | 60 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Mark Hollywood | M | 55 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Kaycia Wilde | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| Netta Blondheim-Shraga | M | - | 2 years | |
| Antal Pearl-Lendner | F | - | 2 years | |
| Chris McDonald | M | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Ali Tehrani | M | 52 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 19 years |
| Arie Belldegrun | M | 74 | 8 years | |
| Ralph Kern | M | 67 | 6 years | |
| Arturo O. Araya | M | 53 | 4 years | |
| Nick Bedford | M | 64 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 16 years |
| Preetam Shah | M | 51 | 2 years | |
| David Tanen | M | 52 | - | |
| Elizabeth Faust | M | 59 | 2 years | |
| Timothy Moore | M | 62 | 3 years | |
| Ran Nussbaum | M | 51 | 4 years | |
| Sankesh Abbhi | M | 38 | 1 years | |
| Greg Mann | M | - | - | |
| Jonathan Peacock | M | 66 | 3 years | |
| Claudine Prowse | M | - | - | |
| Paul L. Jenkinson | M | 64 | 1 years | |
| Eyal Rubin | M | 48 | 2 years | |
| Christine Cassiano | F | - | 1 years | |
| David Bonderman | M | 81 | 6 years | |
| Cynthia Butitta | F | 70 | 4 years | |
| Joshua Kazam | M | 47 | 8 years | |
| Malcolm Taub | M | 78 | 14 years | |
| Robin Washington | F | 60 | - | |
| Ian Clark | M | 62 | - | |
| Franz Humer | M | 76 | 2 years | |
| Farah Champsi | F | 62 | 4 years | |
| Roy Doumani | M | 89 | 6 years | |
| June Almenoff | M | 67 | 6 years | |
| Steven Ruchefsky | M | 61 | 6 years | |
| Brian Sander | M | - | - | |
| Neil Josephson | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 4 years |
| Nadia Agopyan | M | 62 | 4 years | |
| Kavita V. Shah | M | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | - |
| Sidney A. Spector | M | - | 2 years | |
| David Setboun | M | 49 | 3 years | |
| Anthony P Waclawski | M | 62 | 1 years | |
| Jennifer Chow | F | - | - | |
| James Daniel Guylain Priour | M | 57 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | - |
| Roger Sidhu | M | 48 | 2 years | |
| Mary Klem | F | - |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 2 years |
| Michele Korfin | F | 53 | 2 years | |
| Bradley Glover | M | 55 | - | |
| Kirk Taylor | M | - | - | |
| Kathryn O'Driscoll | F | 60 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 3 years |
| Veer Bhavnagri | M | 41 | 4 years | |
| Brett Pletcher | M | 56 | - | |
| Helen Kim | F | 61 | 4 years | |
| Jason Okazaki | M | 48 | - | |
| Chen Schor | M | 51 | 9 years | |
| Christopher Nowers | M | - | - | |
| John Smither | M | 71 | 1 years | |
| Diana Hausman | M | 61 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | 5 years |
| Owen Witte | M | 74 | - | |
| Susan E. Ward | M | - | 2 years | |
| Shawn Tomasello | F | 65 | 3 years | |
| Wayne Godfrey | M | 63 | 1 years | |
| Diane Parks | F | 71 | 2 years | |
| Kimberly A. Metcalf | F | - | - | |
| Revital Geffen-Aricha | M | - | 7 years | |
| Joseph Petroziello | M | - | 2 years | |
| Kim Thacker | M | - | 2 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 67 | 81.71% |
| Canada | 15 | 18.29% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Anthony J. Polverino
- Personal Network
